Qi Wei, Zhang Yazheng, Wang Le, Hou Kai, Li Ting, Lang Jiachun, Cong Hongliang
Department of Cardiology, Tianjin Chest Hospital, Tianjin, China.
Department of Cardiology, Chest Hospital, Tianjin University, Tianjin, China.
Front Cardiovasc Med. 2025 Apr 15;12:1556064. doi: 10.3389/fcvm.2025.1556064. eCollection 2025.
The study presents a case of INOCA attributed to CMVD in a 53-year-old male patient experiencing exertional angina, despite the absence of significant coronary artery stenosis on angiography. The patient presented with reversible myocardial ischemia detected by myocardial perfusion imaging, with an ischemic area accounting for 12% of the left ventricular wall. Diagnostic tests revealed an elevated index of microcirculatory resistance (IMR = 46.3) and a quantitative flow ratio (QFR = 0.94), confirming CMVD. Genetic testing identified a NOTCH1 c.3862G>A variant in the proband and some family members, suggesting a potential contribution to CMVD pathogenesis through impaired vascular remodeling and microcirculatory regulation. After six months of targeted treatment with nicorandil, coenzyme Q10, trimetazidine, and rosuvastatin, the patient's symptoms resolved, and myocardial ischemia reversed. While an MYH7 variant was also detected, its clinical relevance was ruled out due to the family's absence of associated cardiomyopathy phenotypes. The NOTCH1 gene may play a potential role in INOCA caused by CMVD, however, further research is needed to elucidate its underlying regulatory mechanisms. The findings provide a foundation for precise diagnosis and personalized management of INOCA.
该研究报告了一例53岁男性INOCA病例,其病因是CMVD,患者有劳力性心绞痛症状,尽管血管造影显示冠状动脉无明显狭窄。患者经心肌灌注成像检测发现可逆性心肌缺血,缺血面积占左心室壁的12%。诊断性检查显示微循环阻力指数升高(IMR = 46.3)和定量血流比(QFR = 0.94),证实为CMVD。基因检测在先证者及其一些家庭成员中发现了NOTCH1基因c.3862G>A变异,提示可能通过血管重塑受损和微循环调节异常对CMVD发病机制有潜在影响。在用尼可地尔、辅酶Q10、曲美他嗪和瑞舒伐他汀进行六个月的靶向治疗后,患者症状缓解,心肌缺血逆转。虽然还检测到一个MYH7变异,但由于该家族没有相关的心肌病表型,排除了其临床相关性。NOTCH1基因可能在CMVD引起的INOCA中起潜在作用,然而,需要进一步研究以阐明其潜在的调控机制。这些发现为INOCA的精准诊断和个性化管理提供了基础。